Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms. The book goes over the isolation of anticancer agents and the technologyenabled screening process used to develop anticancer drugs. The book also includes discussion of the nutraceuticals and natural productsderived from invertebrates that can be used as part of cancer treatment. Evolutionary Diversity as a Source for Anticancer Molecules also deals with some of the current challenges in the prevention of cancer as well as the side effects of conventional drugs used for cancer patients.This book is a valuable resource for cancer researchers, oncologists, biotechnologists, pharmacologists, and any member of the biomedicalfield interested in understanding more about natural products with anticancer potential. Discusses the application of natural products in place of conventional drugs to minimize the side effects in cancer treatment Explains the relation between evolutionary mechanisms and climate change for production of secondary metabolites

This reference highlights the significance of marine ecosystems, encompassing seaweed beds, seagrasses, coral reefs, mangroves, estuaries, and protected areas, as a remarkable gateway to overcoming healthcare challenges and unlocking a rich trove of bioactive compounds for drug discovery. One of the key highlights of this book is its exploration of the development of marine bio-drugs, a field that demands collaboration among scientists from both academic and industrial fronts. The editors also include a prospective review on marine environments, emphasizing the necessity for big data, collective knowledge sharing, financial support, and streamlined administrative processes, all of which contribute to enhancing innovation in the drug discovery process. Another feature includes reference lists that allow researchers to explore topics of interest in depth. With twelve comprehensive chapters, this book extensively covers marine ecosystem biodiversity, productivity, protected areas, and the intricate interplay of biotic and abiotic factors that shape these ecosystems. Readers will learn about important bioactive compounds within marine organisms and how to use this knowledge to outline a strategy for bio-drug discovery. The book caters to a diverse audience of researchers, students, ecologists, microbiologists, pharmacologists, and biotechnologists who are engaged in studying the dynamic components of marine environments. By providing the latest insights and strategies in the realm of bio-drug discovery from marine resources, this book serves as an invaluable resource for scholars and professionals seeking to tap into the potential of these unique ecosystems.

This book delves into microbial production and its implications for various industries and presents the latest advancements in the field of bioactive compound production by microorganisms. Divided into 16 chapters, the book covers a wide range of topics, starting with the emerging trends in microbial production techniques, followed by the potential of fungi and algae in producing bioactive compounds, and the applications of bioactive compounds in medicine, agriculture, and industry. Contributions from expert scientists emphasize the significance of metabolic engineering and modern analytical techniques for the extraction, purification, and structural characterization of microbial bioactive compounds. The authors also present alternative technologies and methodologies for the recovery and extraction of these compounds from microbial sources and highlight the health-promoting benefits of natural plant-derived bioactive compounds. Particular attention is given to nanocarriers and their potential for managing the delivery of bioactive compounds in therapeutic applications. The importance of actinomycetes and their bioactive potential in the agricultural sector is also discussed. In this book, readers will also find out about the importance of microbial community dynamics in Antarctica, their ecological potential, and their industrial application. The last chapter of the book offers an industrial perspective of microbial pigments and their applications. This book is a valuable resource for researchers, academics, and industry professionals seeking to understand and harness the potential of microbial bioactive compounds for sustainable development, industrial applications, and improved human well-being.

Many natural products are known to have health-promoting pharmaceutical activities. For example, capsaicin, curcumin, epigallocatechin, resveratrol, and quercetin have been reported to possess anti-inflammatory activity. Additionally, bioactive agents such as flavonoids, alkaloids, and terpenoids have shown a protective effect against diseases such as cancer, liver diseases, cardiovascular diseases, neurological disorders, diabetes mellitus, and more. Pharmacological Benefits of Natural Agents compiles the beneficial effects of bioactive natural agents with reference to many disease conditions and considers the challenges and future directions for their use. Covering key topics such as cancer, pharmaceutical activities, bioactive compounds, and treatments, this reference work is ideal for medical professionals, pharmacists, biologists, policymakers, researchers, scholars, practitioners, academicians, instructors, and students.

Functional Metagenomics: Microbial Diversity, Interaction, and Application in Bioremediation uses a 20-chapter, easy-to-understand format to centralize the practical application ideas for functional metagenomics. This important resource not only includes chapters on next-generation sequencing technologies to study important biogeochemical cycles, degradation pathways and detoxification, but also gives insight into several tools that have been developed to integrate metadata and sequence data, allowing downstream comparative analyses of different datasets using several ecological indices.Content further explains the newly developed techniques for sequencing DNA; generating shorter fragments than Sanger sequencing techniques to quickly read larger sequences in a shorter amount of time. The content finally explores the role of metagenomics in studying microbial diversity, interaction and application in bioremediation studies and gives the reader overall detailed information regarding metagenomics, its application as well as techniques. Provides comprehensive information to readers on state-of-the-art applications in metagenomics Summarizes our current knowledge of the use of metagenomics and gives a novel and powerful insight into the already existing bioremediation process Gives an overall picture of metagenomics, its application, processes, and future prospects in the field of bioremediation

The full colour, beautifully illustrated Modern Medicines from Plants: Botanical histories of some of modern medicine’s most important drugs features information on plants from which we obtain modern prescription medicines. It outlines their historical uses as herbal medicines in the past two millennia, using primary sources, and describes how extracts from them, and their semisynthetic and synthetic derivatives, were developed to be today’s therapeutic drugs and diagnostic chemicals. This book describes medicinal plants and their habitats, the diseases that their medicines treat, and the science of how they work. This amazing and unique book is a wonderful read for those with an interest in both herbal and prescription medicines. Written with authority by physicians and gardeners at the Garden of Medicinal Plants at the Royal College of Physicians, London, chapters detail the history and modern scientific research on plants and their medicines. It is very useful to physicians, pharmacists, herbalists, historians and gardeners, bringing together information from every discipline to make it a work of interest as well as reference. Features · Written for people interested in medicinal plants, where medicines come from, and how they treat our diseases. · Contains information on 50 plants, mostly growing in the medicinal garden of the Royal College of Physicians in London, describing how they became the source of modern pharmaceutical medicines. · Describes medicinal uses of plants in Classical Greece as written by Dioscorides, Pliny and Galen, through the flowering of Arabic medicine by physicians such as Paulus Aegineta, Mesue and Avicenna to the 12th to 14th century compilations of Serapion and Sylvaticus and the European Renaissance of Peter Treveris, William Turner, Leonard Fuchs, Pietro Mattioli, John Gerarde, John Parkinson, Nicholas Culpeper, and many others to the pharmacopoeias of the 16th century to the present day. · Fully referenced including a glossary for explanation of technical terms.